BPC-157

Gastric Pentadecapeptide: 15-amino acid sequence (GEPPPGKPADDAGLV), ≥99% purity, 4-pack format
NO System Modulation: VEGFR2-Akt-eNOS and Src-Caveolin-1-eNOS pathway research
Tissue Repair Studies: FAK-paxillin pathway activation and angiogenic signaling

Manufacturer: RiboCore

Availability: In stock

SKU: RC-BPC-157-10MG-4-PACK

Old price: $200.00

Price: $150.00

Ship to

Shipping Method

Estimated Delivery

Price

No shipping options

Technical Specifications

Characteristic	Value
CAS Number	137525-51-0
Molecular Weight	1,419.55 Da
Purity	≥99% (HPLC)
Form	Lyophilized white powder
Pack Configuration	4 individually sealed vials (4 x 5 mg = 20 mg total)

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. First described by Sikiric and colleagues in 1993 at the University of Zagreb, Croatia, this 15-amino acid peptide has been the subject of extensive preclinical research investigating its potential cytoprotective, angiogenic, and tissue repair properties. With over 150 peer-reviewed publications spanning more than three decades, BPC-157 represents one of the most extensively studied gastric-derived peptides in regenerative medicine research.

The peptide demonstrates exceptional stability compared to many bioactive peptides, remaining stable in human gastric juice for more than 24 hours and maintaining biological activity across a wide pH range. This stability is attributed to its specific amino acid composition and the structural support provided by four proline residues, making it resistant to common peptidase degradation pathways.

Key Research Highlights

Research Area	Key Finding
Musculoskeletal Repair	Complete restoration of walking patterns and muscle-to-bone reattachment in quadriceps detachment model (Matek et al., 2025)
Spinal Cord Injury	All BPC-157-treated rats showed consistent clinical improvement and increasingly better motor function; resolved spasticity by day 15 (Perovic et al., 2019)
Distant Organ Protection	Significantly increased total antioxidant status and reduced oxidative stress in liver, kidney, and lung during ischemia-reperfusion injury (Demirtas et al., 2025)
Clinical Safety	IV infusion up to 20 mg in healthy adults produced no adverse effects on cardiac, hepatic, renal, or metabolic biomarkers (Lee and Burgess, 2025)

Research Applications

Gastrointestinal tract research and mucosal integrity studies
Musculoskeletal tissue healing (tendon, ligament, muscle, bone)
Angiogenesis and vascular research
Wound healing and dermatological research
Neurological and neuroprotective research
Cardiovascular system research
Ischemia-reperfusion and organ protection research
Cell signaling and molecular biology research